Subgroup analyses of efficacy from a phase III study comparing SB3 (trastuzumab biosimilar) with reference trastuzumab in early breast cancer patients
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2018-10, Vol.29, p.viii69-viii69 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | viii69 |
|---|---|
| container_issue | |
| container_start_page | viii69 |
| container_title | Annals of oncology |
| container_volume | 29 |
| creator | Cortes Castan, J. Pegram, M. Pivot, X. Curigliano, G. Lim, J.Y. Song, S. Yoon, Y.C. |
| description | |
| doi_str_mv | 10.1093/annonc/mdy270.212 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdy270_212</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419486407</els_id><sourcerecordid>32137910</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2302-f62644e7a41a8c197944c804d558775b9ec47ec5ff9fd5d32bcc766cf5db3eb53</originalsourceid><addsrcrecordid>eNp9kEtP3TAUhK2qVbml_QHdVGdZFgE_4vharABBuRJSF7TryI9jcHXzkJ1QhR_C761R2ooVqyONZkZzPkI-M3rMqBYnpu-H3p10fuGKHnPG35ANk42utrRmb8mGai4qJUV9QD7k_ItS2miu35MDwZlQmtENebqd7V0a5hFMb_ZLxgxDAAwhOuMWCGnowMB4bzLCbreDPM1-ATd0o0mxv4PbcwFfp2SK_jh3xoKNQ45d3Jt0BL_jdA8JAybsHcJLW-wBTdovYBMWFZwpjgSjmSL2U_5I3gWzz_jp7z0kP68uf1xcVzffv-0uzm4qxwXlVWh4U9eoTM3M1jGtdF278ryXcquUtBpdrdDJEHTw0gtunVNN44L0VqCV4pCwtdelIecytR1T7ExaWkbbZ8btyrhdGbeFccl8WTPjbDv0_xP_oBbD6WrAsvwhYmqzi88EfEzoptYP8ZX6Pzudkr4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Subgroup analyses of efficacy from a phase III study comparing SB3 (trastuzumab biosimilar) with reference trastuzumab in early breast cancer patients</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Cortes Castan, J. ; Pegram, M. ; Pivot, X. ; Curigliano, G. ; Lim, J.Y. ; Song, S. ; Yoon, Y.C.</creator><creatorcontrib>Cortes Castan, J. ; Pegram, M. ; Pivot, X. ; Curigliano, G. ; Lim, J.Y. ; Song, S. ; Yoon, Y.C.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy270.212</identifier><identifier>PMID: 32137910</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Annals of oncology, 2018-10, Vol.29, p.viii69-viii69</ispartof><rights>2018 THE AUTHORS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32137910$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cortes Castan, J.</creatorcontrib><creatorcontrib>Pegram, M.</creatorcontrib><creatorcontrib>Pivot, X.</creatorcontrib><creatorcontrib>Curigliano, G.</creatorcontrib><creatorcontrib>Lim, J.Y.</creatorcontrib><creatorcontrib>Song, S.</creatorcontrib><creatorcontrib>Yoon, Y.C.</creatorcontrib><title>Subgroup analyses of efficacy from a phase III study comparing SB3 (trastuzumab biosimilar) with reference trastuzumab in early breast cancer patients</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kEtP3TAUhK2qVbml_QHdVGdZFgE_4vharABBuRJSF7TryI9jcHXzkJ1QhR_C761R2ooVqyONZkZzPkI-M3rMqBYnpu-H3p10fuGKHnPG35ANk42utrRmb8mGai4qJUV9QD7k_ItS2miu35MDwZlQmtENebqd7V0a5hFMb_ZLxgxDAAwhOuMWCGnowMB4bzLCbreDPM1-ATd0o0mxv4PbcwFfp2SK_jh3xoKNQ45d3Jt0BL_jdA8JAybsHcJLW-wBTdovYBMWFZwpjgSjmSL2U_5I3gWzz_jp7z0kP68uf1xcVzffv-0uzm4qxwXlVWh4U9eoTM3M1jGtdF278ryXcquUtBpdrdDJEHTw0gtunVNN44L0VqCV4pCwtdelIecytR1T7ExaWkbbZ8btyrhdGbeFccl8WTPjbDv0_xP_oBbD6WrAsvwhYmqzi88EfEzoptYP8ZX6Pzudkr4</recordid><startdate>201810</startdate><enddate>201810</enddate><creator>Cortes Castan, J.</creator><creator>Pegram, M.</creator><creator>Pivot, X.</creator><creator>Curigliano, G.</creator><creator>Lim, J.Y.</creator><creator>Song, S.</creator><creator>Yoon, Y.C.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201810</creationdate><title>Subgroup analyses of efficacy from a phase III study comparing SB3 (trastuzumab biosimilar) with reference trastuzumab in early breast cancer patients</title><author>Cortes Castan, J. ; Pegram, M. ; Pivot, X. ; Curigliano, G. ; Lim, J.Y. ; Song, S. ; Yoon, Y.C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2302-f62644e7a41a8c197944c804d558775b9ec47ec5ff9fd5d32bcc766cf5db3eb53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cortes Castan, J.</creatorcontrib><creatorcontrib>Pegram, M.</creatorcontrib><creatorcontrib>Pivot, X.</creatorcontrib><creatorcontrib>Curigliano, G.</creatorcontrib><creatorcontrib>Lim, J.Y.</creatorcontrib><creatorcontrib>Song, S.</creatorcontrib><creatorcontrib>Yoon, Y.C.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cortes Castan, J.</au><au>Pegram, M.</au><au>Pivot, X.</au><au>Curigliano, G.</au><au>Lim, J.Y.</au><au>Song, S.</au><au>Yoon, Y.C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Subgroup analyses of efficacy from a phase III study comparing SB3 (trastuzumab biosimilar) with reference trastuzumab in early breast cancer patients</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2018-10</date><risdate>2018</risdate><volume>29</volume><spage>viii69</spage><epage>viii69</epage><pages>viii69-viii69</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32137910</pmid><doi>10.1093/annonc/mdy270.212</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2018-10, Vol.29, p.viii69-viii69 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdy270_212 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | Subgroup analyses of efficacy from a phase III study comparing SB3 (trastuzumab biosimilar) with reference trastuzumab in early breast cancer patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T19%3A19%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Subgroup%20analyses%20of%20efficacy%20from%20a%20phase%20III%20study%20comparing%20SB3%20(trastuzumab%20biosimilar)%20with%20reference%20trastuzumab%20in%20early%20breast%20cancer%20patients&rft.jtitle=Annals%20of%20oncology&rft.au=Cortes%20Castan,%20J.&rft.date=2018-10&rft.volume=29&rft.spage=viii69&rft.epage=viii69&rft.pages=viii69-viii69&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy270.212&rft_dat=%3Cpubmed_cross%3E32137910%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32137910&rft_els_id=S0923753419486407&rfr_iscdi=true |